Skip to content

Symptom Clusters in Cancer Patients and Their Caregivers- a Longitudinal Study

Advancing the Science of Symptom Management and Support for Cancer Patients and Their Caregivers

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00769301
Enrollment
570
Registered
2008-10-09
Start date
2008-11-30
Completion date
2011-12-31
Last updated
2018-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Depression, Fatigue, Pain, Sleeping Problems

Keywords

Symptoms, pain, fatigue, depression, sleeplessness, genetic markers, caregiver burden.

Brief summary

The complexity of cancer patients' symptoms and health problems constitutes considerable distress and burden for patients and their family caregivers. To help them manage the illness effectively, there is a need to better understand the complexity of symptoms and symptom clusters in patients and caregivers. Therefore, the purpose of this research is to explore a set of important fundamental research questions to advance the scientific knowledge of cancer patients' and caregivers' symptoms, symptom clusters and health-related quality of life. The investigators will follow 500 cancer patients and their caregivers with repeated measures over 6 months to assess their symptoms, symptom clusters, and quality of life over time. Caregiver burden will also be examined in the caregivers.

Detailed description

The specific aims of the study, where we will follow 500 cancer patients and their caregivers with repeated measures over 6 months, are to: 1. Explore cancer patients' symptoms, symptom clusters and symptom changes over time; and identify subgroups of patients with different symptom clusters. 2. Identify genomic markers for the different patient subgroups. 3. Explore symptoms, symptom clusters and burden in caregivers of cancer patients. 4. Explore relationships between patients' and caregivers' symptoms, symptom clusters, quality of life and caregiver burden. Patients will be asked to complete questionnaires to collect demographic characteristics and self-reported medical history information, a general symptom inventory, specific measures of the symptoms of pain, sleep disturbance, fatigue, depression, functional status and quality of life. The patients' medical record will be reviewed for disease and treatment information. The caregivers will also be asked to complete questionnaires about a general symptom inventory, specific measures of the symptoms of pain, sleep disturbance, fatigue, depression, functional status, quality of life and caregiver burden. Data Analyses will be done to identify symptom clusters of the different symptoms, and to identify patient subgroups based on their symptom experience and quality of life. Variations in symptom clusters and quality of life over time will also be evaluated. Genetic analyses will also be done in the patients.

Interventions

None listed

Sponsors

University of California, San Francisco
CollaboratorOTHER
Oslo University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

for patients are: * diagnosed with breast, colon, head and neck or ovarian cancer * receiving active treatment for their cancer (chemo- or radiation therapy) * above 18 years of age * able to read / write /speak Norwegian. Inclusion criteria for caregivers: * above 18 years * read and speak Norwegian * and written informed consent.

Exclusion criteria

* patients who had received radiation on the brain as this may affect their abilities to reliably complete questionnaires.

Design outcomes

Primary

MeasureTime frame
Physical functioning and quality of life5 to 8 times during 6 months

Secondary

MeasureTime frame
Symptoms will be measured both in patients and caregivers. Caregiver burden will be measured in the caregivers. A blood sample for genetic testing will be taken from the patients once5 to 8 times during 6 months for patients. Three times during 6 months for caregivers.

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026